Matches in Wikidata for { <http://www.wikidata.org/entity/Q37509952> ?p ?o ?g. }
- Q37509952 description "article científic" @default.
- Q37509952 description "article scientifique" @default.
- Q37509952 description "articolo scientifico" @default.
- Q37509952 description "artigo científico" @default.
- Q37509952 description "artículu científicu espublizáu en 2010" @default.
- Q37509952 description "bilimsel makale" @default.
- Q37509952 description "scientific article published on June 2010" @default.
- Q37509952 description "vedecký článok" @default.
- Q37509952 description "vetenskaplig artikel" @default.
- Q37509952 description "videnskabelig artikel" @default.
- Q37509952 description "vědecký článek" @default.
- Q37509952 description "wetenschappelijk artikel" @default.
- Q37509952 description "wissenschaftlicher Artikel" @default.
- Q37509952 description "наукова стаття, опублікована в червні 2010" @default.
- Q37509952 description "научни чланак" @default.
- Q37509952 description "مقالة علمية نشرت في يونيو 2010" @default.
- Q37509952 name "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 name "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 name "A Phase II study of" @default.
- Q37509952 type Item @default.
- Q37509952 label "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 label "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 label "A Phase II study of" @default.
- Q37509952 prefLabel "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 prefLabel "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 prefLabel "A Phase II study of" @default.
- Q37509952 P1433 Q37509952-9C5A8F8B-3EF1-461F-91F5-2BECE4EDA2CB @default.
- Q37509952 P1476 Q37509952-A9998112-FEAA-4D7D-914B-A4C7B855ACF3 @default.
- Q37509952 P2093 Q37509952-38823CC1-71BA-413E-9B65-57CA7D9C0FE0 @default.
- Q37509952 P2093 Q37509952-93FAFD11-F439-4B13-A038-09552B1A2C2F @default.
- Q37509952 P2093 Q37509952-AA4B9EA0-190C-47E7-8BD4-1E19770F3925 @default.
- Q37509952 P2093 Q37509952-B14DD4FF-9D1A-4A1A-8540-0B66D9067DB4 @default.
- Q37509952 P2093 Q37509952-D405D6EF-6CA3-4D1C-AB0A-313D0706CB2D @default.
- Q37509952 P2860 Q37509952-00AF0757-0336-4B6C-807F-DA3C9B0056B1 @default.
- Q37509952 P2860 Q37509952-03E06ABC-40C6-4A38-AEBA-2FAE5DDBCFA6 @default.
- Q37509952 P2860 Q37509952-09848A43-01F4-457E-AD54-E3A6182B125A @default.
- Q37509952 P2860 Q37509952-0D7083E7-F5FF-4B9E-AE60-2D3F86156248 @default.
- Q37509952 P2860 Q37509952-153C6CD4-415E-4D52-B6C4-1FE6F5D06CDC @default.
- Q37509952 P2860 Q37509952-2160A078-4A30-497E-9095-50E8C09692F9 @default.
- Q37509952 P2860 Q37509952-2747593A-F1AC-406D-ADAD-1EE41433A45A @default.
- Q37509952 P2860 Q37509952-42E8CF36-2847-4A21-874B-AA50FFB15E26 @default.
- Q37509952 P2860 Q37509952-6144932C-5F03-464A-945A-E2FF82FDFE84 @default.
- Q37509952 P2860 Q37509952-6582076F-7151-4637-A831-47B243F9286E @default.
- Q37509952 P2860 Q37509952-670C2DBD-F1A6-481F-9203-A251247036D4 @default.
- Q37509952 P2860 Q37509952-6B07AF2B-CD92-401C-B8A5-097B232C0F9E @default.
- Q37509952 P2860 Q37509952-6D48FA36-0EA9-4E4B-BB5F-86B231F69FFF @default.
- Q37509952 P2860 Q37509952-77FE3AFB-7A1E-4152-BDB2-A2395D292B3D @default.
- Q37509952 P2860 Q37509952-817BC595-6680-4DE7-8874-AF956768D8E2 @default.
- Q37509952 P2860 Q37509952-823E86A9-A1ED-4F2B-8DBE-21E6422868FA @default.
- Q37509952 P2860 Q37509952-8361FCC8-718B-4307-97FA-C78BDBFC5CAC @default.
- Q37509952 P2860 Q37509952-86BDDD4E-AA19-4211-AB55-111E8DAC0686 @default.
- Q37509952 P2860 Q37509952-949A11C6-130F-4A11-8ED8-55BA6216BA46 @default.
- Q37509952 P2860 Q37509952-A18B0FAE-E557-48CB-A9CE-946B6D30DA40 @default.
- Q37509952 P2860 Q37509952-AC408904-DC17-43F5-8AB2-818F135E2B06 @default.
- Q37509952 P2860 Q37509952-B4FCA2B9-10DE-473B-83B1-D4FD12A41A65 @default.
- Q37509952 P2860 Q37509952-B53971F7-B97B-437B-9602-1EE947D16545 @default.
- Q37509952 P2860 Q37509952-B7CF248C-E217-4D87-8950-E8503FC13F2C @default.
- Q37509952 P2860 Q37509952-C004B154-91D5-4295-8EB2-9C4F8D597756 @default.
- Q37509952 P2860 Q37509952-C14E68A7-E31F-4DEB-B17B-23629122051F @default.
- Q37509952 P2860 Q37509952-C34A60AD-210E-4362-B6FD-F155B612ACB0 @default.
- Q37509952 P2860 Q37509952-CC2AC0FA-84F7-4788-A2C3-E6FFBE1E4371 @default.
- Q37509952 P2860 Q37509952-D458945C-BA9D-444E-8C6F-FC2A96F6BFA4 @default.
- Q37509952 P2860 Q37509952-DCBFB154-3A03-474D-AD93-DFB3C737BE54 @default.
- Q37509952 P2860 Q37509952-DDC3A33B-5DC6-4354-B47A-09E073E334E8 @default.
- Q37509952 P2860 Q37509952-E0645664-14E7-4A60-AC87-0C207776320B @default.
- Q37509952 P2860 Q37509952-EAEBE9D1-FB56-492F-91D5-986D77F0DC6C @default.
- Q37509952 P2860 Q37509952-FB55BFAE-3FBF-4975-929C-7175BD245078 @default.
- Q37509952 P2860 Q37509952-FF3B79C8-6105-464D-87A4-D92877CBAA36 @default.
- Q37509952 P304 Q37509952-9043C02F-A2FA-45F0-AE8D-594B17648EB0 @default.
- Q37509952 P31 Q37509952-E502BA93-EF01-412B-B9BF-770014306D53 @default.
- Q37509952 P356 Q37509952-90BDD25A-D5B7-4D38-83AA-655CFBD46F3F @default.
- Q37509952 P433 Q37509952-9FE7763B-AFF1-4F43-B5A1-4DEFECE75203 @default.
- Q37509952 P478 Q37509952-E0A10645-AD57-46C6-AD69-5A8431F5E726 @default.
- Q37509952 P50 Q37509952-033553C4-23F6-4F88-BB09-84DA57839077 @default.
- Q37509952 P50 Q37509952-3A5F0E5C-B0C8-4717-B9BE-F34230E1218B @default.
- Q37509952 P50 Q37509952-46FD2DE1-4240-47FD-B5B5-B3276162A168 @default.
- Q37509952 P50 Q37509952-869B2394-8055-40EE-A930-A71150416D3E @default.
- Q37509952 P50 Q37509952-8D871DA4-0E6B-42DF-A381-0D4A78865FC4 @default.
- Q37509952 P50 Q37509952-AD71AF6A-B5A4-4280-A987-333986EAE99A @default.
- Q37509952 P50 Q37509952-B8485BEB-0496-486A-99AF-75385E8B6E71 @default.
- Q37509952 P50 Q37509952-BCFF066A-ABF3-4E43-88E0-C12DC57413CC @default.
- Q37509952 P50 Q37509952-C1052482-9219-4348-A5DA-04DFA4C5E0D1 @default.
- Q37509952 P50 Q37509952-C9921DB8-B67A-4A85-B129-CB62D6E1FD10 @default.
- Q37509952 P50 Q37509952-CD0CB0EB-D994-4511-B419-D3431BD74443 @default.
- Q37509952 P50 Q37509952-CFF7BB13-09FA-4365-90AE-75BA55DE0E2F @default.
- Q37509952 P50 Q37509952-D52A2317-2EED-45C0-A35E-C85D2F2159D8 @default.
- Q37509952 P50 Q37509952-D79D83CB-16DE-4763-A8E1-4A74FDC06709 @default.
- Q37509952 P50 Q37509952-FE588A05-87A1-4B55-8D3D-20CA3FDAFFC7 @default.
- Q37509952 P577 Q37509952-103459FA-8F41-472F-A53C-93CF4B27FB0E @default.
- Q37509952 P5875 Q37509952-A413EA62-51E4-4673-A638-103CEC23AB86 @default.
- Q37509952 P698 Q37509952-379E3F8B-18F9-43AD-B4FB-6F79AB2283D0 @default.
- Q37509952 P932 Q37509952-9BD80672-1F1F-4670-B24F-C677460924D7 @default.
- Q37509952 P356 AJH.21696 @default.
- Q37509952 P698 20513117 @default.
- Q37509952 P1433 Q4744246 @default.
- Q37509952 P1476 "A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma" @default.
- Q37509952 P2093 "Gregory A Wiseman" @default.
- Q37509952 P2093 "Jake Allred" @default.
- Q37509952 P2093 "Krista M Laumann" @default.
- Q37509952 P2093 "Patrick B Johnston" @default.